Non-CME/CE Industry
Overview
Understand the clinical and economic burden of influenza in the United States (US) and the continued decline in influenza vaccination coverage across the lifespan
Discuss and explore advancements in influenza vaccine technology
Explore the potential benefits of cell-based and adjuvanted influenza vaccines, including health outcomes
Focus on insights from real-world evidence (RWE) across multiple influenza seasons regarding relative vaccine effectiveness and the impact on patient outcomes
SPONSORED BY
CSL Seqirus